Clinical Trials Browser

Terminated × Breast Neoplasms × Drug Therapy × Clear all

NCT02806258 2025-12-29

Néo-APBI-01

Phase 1/2 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03393741 2024-06-25

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

Breast Neoplasms

NCT03386162 2022-11-28

SAFIR-PI3K

Phase 2 Terminated

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT02000596 2022-05-27

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

Phase 3 Terminated

29 enrolled 6 charts

Breast Neoplasms

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast Neoplasms

NCT01928615 2014-09-29

LISAH

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms

NCT00851110 2009-02-25

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

Phase 2 Terminated

Breast Neoplasms